1. Homepagina
  2. Aandelen
  3. Japan
  4. Japan Exchange
  5. Terumo Corporation
  6. Nieuws
  7. Persberichten
    4543   JP3546800008

TERUMO CORPORATION

(4543)
  Rapport
Vertraagde tijd Japan Exchange  -  04:30 29-06-2022
4075.00 JPY   -0.88%
26/05TERUMO CORPORATION : UBS is Neutraal over het aandeel
MM
16/05Terumo kondigt wijziging aan in de indicatie voor Dexcom G6 CGM-systeem in Japan
CI
13/05Terumo kondigt hoger dividend af als de toerekenbare winst in FY22 met 15% stijgt; plant inkoop van eigen aandelen ter waarde van $389 miljoen
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť TERUMO CORPORATION
28/06Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene the..
AQ
23/06TERUMO : Plasma Innovation Business Seminar (PDF 3.62 MB)
PU
22/06TERUMO : Announces Voting Results for the Election of Directors (PDF 90.72 KB)
PU
17/06TERUMO : NHS England Chooses Spectra Optiaģ Apheresis System as Part of MedTech Funding Ma..
PU
16/06NHS England chooses Spectra Optia(R) Apheresis System as part of MedTech Funding Mandat..
AQ
15/06TERUMO : Holmium-166 SIRT Demonstrates Safety and Efficacy in the Treatment of Hepatocellu..
PU
07/06TERUMO : Appoints Three Associates as the Newest Terumo Fellow
PU
03/06TERUMO : Radboudumc and Terumo Europe N.V. Sign Collaboration Agreement
PU
02/06TERUMO : Notification Regarding Status of Acquisition of the Company's Own Shares (PDF 103..
PU
26/05TERUMO : Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
PU
27/04TERUMO : Blood and Cell Technologies Receives $10.6M Contract From U.S. Government to Cont..
PU
27/04TERUMO : Aortic Announces Enrolment of Patients in an All-Comers TREO AAA Study
PU
21/04TERUMO : Aortic Announces US FDA Approval for Thoraflex Hybrid Device
PU
01/04TERUMO : Launches New Brand ‘Terumo Medical Care Solutions' as a Promise to Provide ..
PU
29/03TERUMO : Vietnam Factory to Implement Large-scale Solar Panels in FY2022 Towards Realizati..
PU
29/03TERUMO : Announces Commitment to Achieve Carbon Neutrality by 2040Actions Include Revision..
PU
29/03TERUMO : Announces Commitment to Achieve Carbon Neutrality by 2040
PU
18/03TERUMO : Aortic Announces US FDA Breakthrough Device Designation for RelayBranch
PU
10/03TERUMO : U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technol..
PU
10/03TERUMO : U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technol..
PU
02/03TERUMO : Selected for a Major ESG Investment Index 'MSCI Japan ESG Select Leaders Index' f..
PU
01/03Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitab..
AQ
18/02TERUMO : Selective Internal Radiation Therapy (SIRT) to be evaluated in Germany as curativ..
PU
14/02TERUMO : "Q&A Session at the Financial Results Briefing for the Third Quarter of FYE 3/202..
PU
10/02TERUMO : "Financial Results for the Third Quarter of FYE 3/2022"(with note)(..
PU
09/02TERUMO : "Financial Results for the Third Quarter of FYE 3/2022"(1.0 MB)
PU
09/02TERUMO : 3rd Quarter Financial Results for FYE 3/2022(354.2 KB)
PU
09/02TERUMO : to Implement New Executive Officers' Management System
PU
14/01TERUMO : Aortic Announces First Commercial Implant of "Upon Request" RelayPro Endovascular..
PU
2021TERUMO : "General Hospital Company"(3.9 MB)
PU
2021TERUMO : "Q&A Session at the 5-Year Growth Strategy with a 10-Year Vision"(288.1 KB)
PU
2021TERUMO : Corporate Governance Report
PU
2021TERUMO : Establishes "Terumo Group Sustainability Policy" and Revises the Sustainability P..
PU
2021TERUMO : "Blood and Cell Technologies Company"
PU
2021TERUMO : "Cardiac and Vascular Company"
PU
2021TERUMO : "General Hospital Company"
PU
2021TERUMO : "Corporate"(6.2 MB)
PU
2021TERUMO : Announces 5-Year Growth Strategy (GS26) to Deliver Solutions to 21st Century Heal..
PU
2021TERUMO : Aortic Announces PMDA Approval for RelayPro Endovascular Device in Japan
PU
2021TERUMO : Aortic Announces Launch and First Commercial Use of the Aortic Balloon Device
PU
2021TERUMO : and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Exp..
PU
2021GENERAL ANNOUNCEMENT : :Notice Regarding Completion of Conversion for Zero Coupon Converti..
PU
2021Terumo Report 2021
PU
2021"Q&A Session at the Financial Results Briefing for the First Half of FYE 3/2022"(217.9 ..
PU
2021Terumo to Develop Smartphone-type Device to Control Insulin Pump
PU
2021"Financial Results for the First Half of FYE 3/2022"(with note)(1.0 MB)
PU
2021"Financial Results for the First Half of FYE 3/2022"(969.4 KB)
PU
2021Consolidated Financial Results for the Second Quarter Ended September 30, 2021〔I..
PU
2021Terumo Revises Interim Dividend Distribution and Year-End Dividends Forecast for Fiscal..
PU
2021"A NEW STAGE IN US MARKET STRATEGY : Utilize M&A to further build capability and expand pr..
PU
2021"Financial Results for the First Half of FYE 3/2022"(969.0 KB)
PU
20211st Half Financial Results for FYE 3/2022(353.5 KB)
PU
2021Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations i..
AQ
2021TERUMO : Blood and Cell Technologies Opens Manufacturing Facility in Costa RicaThe company..
PU
2021TERUMO : Aortic Announces PMDA Approval and First Commercial Implant of TREO Endovascular ..
PU
2021TERUMO : Blood and Cell Technologies is collaborating with BioCentriq to provide technolog..
PU
2021TERUMO : Aortic Announces First Implant of Landmark Thoracoabdominal Hybrid Device
PU
2021TERUMO : Aortic Announces Launch of Landmark Global Surgical Graft Study
PU
2021TERUMO : CVS Fully Exits Consent Decree
PU
2021TERUMO : India releases Special Postal Cover and My Stamp to Commemorate 100 years of Teru..
PU
2021TERUMO : Celebrates 100-Year Anniversary in Asia with an Eye to the Future
PU
2021TERUMO : Aortic Announces First Commercial Implants of RelayPro Endovascular Device in the..
PU
2021TERUMO : Blood and Cell Technologies announces a new software update for its Finiaģ Fill a..
PU
2021TERUMO : Etiometry and Terumo Cardiovascular Announce Partnership to Deliver Enhanced Moni..
PU
2021TERUMO : MASTER DAPT, a Landmark Trial on Abbreviated DAPT Post-implantation of Terumo's U..
PU
2021TERUMO : Revises its Full-Year Financial Guidance for FY2021
PU
2021TERUMO : IFRS Financial Results for the Third Quarter of the Fiscal Year Ending March 31, ..
PU
2021TERUMO : and UMCU strengthen their partnership to develop solutions in Interventional Onco..
AQ
2021TERUMO : Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund..
AQ
2021TERUMO : Corporate Governance Report
PU
2021TERUMO : is building a Global Therapeutic Interventional Oncology team to offer more thera..
AQ
2021TERUMO : A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device..
AQ
2020TERUMO : North America Brings Intelligent Enterprise to Life During Worldwide Pandemic
AQ
2020TERUMO : Acquires Quirem Medical to Enhance Its Interventional Oncology Field
AQ
2018TERUMO : Announces European Launch of Biosimilar Using Terumo's PLAJEX™ Pre-fillable..
PU
1  2  3Volgende
Volgende evenement op TERUMO CORPORATION